02 July 2018
$30 Million Credit Facility with Hercules Technology Growth Capital Secured to Support Intended Commercialisation of BARHEMSYS™ in the UK
LSX CEO Forum, London, England
June 27
American Society of Metabolic and Bariatric Surgery (ASMBS), New York City
June 14-16
Jefferies 2018 Healthcare Conference, New York City
June 5-8
2018 BIO international Convention, Boston, MA
June 4-7
American Society of Health-System Pharmacists (ASHP), Denver, CO
June 2-6
Bio€quity Europe, Ghent, Belgium
May 14-16
Society for Ambulatory Anesthesia (SAMBA), Miami, FL
May 3-5
American College of Obstetricins & Gynaecology (ACOG), Austin, TX
April 27-30
2018 World Congress on Regional Anesthesia & Pain Medicine (ASRA), New York City
April 19 - 21
11 April 2018
UK Commercial Operations for BARHEMSYS™ (formerly BAREMSIS®) Expanded Four Key Appointments
02 March 2018
Lan Chem Laboratories - Prospectus
02 March 2018
Lan Chem Laboratories Successfully Prices Its Initial Global Offering At Eur 3.60 Per Share Raising Eur 40 Million
05 February 2018
Lan Chem Laboratories Announces its Intention to Launch an Initial Global Offering and to List its Shares on Euronext Brussels
13 February 2017
Positive Results From 4th And Final Pivotal Phase 3 Trial Of BAREMSIS® For Rescue Treatment Of PONV
03 December 2015
Dr Patrick Vink To Succeed Ian Kent As Non-Executive Chairman